www.RAandIL6.com
Now, health care providers ordering the Fluzone vaccine portfolio of products can benefit from customized solutions that help protect their patients against influenza.

Confirm your order now to be enrolled in the Fluzone Partners Program and take full advantage of program benefits. Login to VaccineShoppe.com® or call 1-800-VACCINE (1-800-822-2463).
The Fluzone Partners Program provides:
A wide range of quality vaccines for your patients from 6 months to 65 years of age and older Convenient, one-stop e-commerce website with online ordering, tracking, and account management tools Financial savings, performance credit, and returnabilitya,b Reimbursement support services available online and by telephone Customized tools and services for your practice
a Returnable upon expiration.
b Reservations must be placed by a certain date to receive credits and discounts.
IMPORTANT SAFETY INFORMATION

INDICATION
Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B virus(es) contained in each vaccine.

Fluzone Quadrivalent vaccine is approved for use in persons 6 months of age and older. Fluzone Intradermal Quadrivalent vaccine is approved for use in persons 18 through 64 years of age. Fluzone High-Dose vaccine is approved for use in persons 65 years of age and older.

SAFETY INFORMATION
The most common local and systemic adverse reactions to Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines include pain, and swelling at the injection site (also pruritus in adults receiving Fluzone Intradermal Quadrivalent vaccine); myalgia, malaise, headache, and fever (also irritability, abnormal crying, drowsiness, appetite loss, and vomiting in young children receiving Fluzone Quadrivalent vaccine). Pruritus, erythema, swelling, and induration at the injection site occurred more frequently with trivalent Fluzone Intradermal vaccine than with trivalent Fluzone vaccine. Other adverse reactions may occur.

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines should not be administered to anyone with a known hypersensitivity (eg, anaphylaxis) to any vaccine component, including egg protein or thimerosal (the multidose vial is the only presentation containing thimerosal), or to a previous dose of any influenza vaccine.

If Guillain-Barré syndrome has occurred within 6 weeks following previous influenza vaccination, the decision to give Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, or Fluzone High-Dose vaccine should be based on careful consideration of the potential benefits and risks. Vaccination with Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, or Fluzone High-Dose vaccine may not protect all individuals.
 

Before administering Fluzone QuadrivalentFluzone Intradermal Quadrivalent, or Fluzone High-Dose vaccine, please see full Prescribing Information.

To order the Fluzone portfolio of vaccines or learn more about the Fluzone Partners Program, log on to VaccineShoppe.com or call 1-800-VACCINE (1-800-822-2463).

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are manufactured and distributed by Sanofi Pasteur Inc.